ipamorelin cjc 1295 therapy dallas CJC-1295 (no DAC) 5mg / 5mg CJC-1295 Ipamorelin Cost: Medical Clinic

38 H 49 N 9 O 5 Ipamorelin Mechanism of Action Acts as a selective agonist of the growth-hormone secretagogue receptor (GHS-R1a, the ghrelin receptor) on pituitary somatotrophs

CJC-1295 (No DAC) is a modified growth hormone releasing hormone (GHRH) analog designed for research related to pituitary stimulation mechanisms, while Ipamorelin is a selective pentapeptide studied for its interaction with growth hormone secretagogue receptors (GHS-R)

(Eur J Endocrinol 1998) : caracterizacin original

This is a fundamentally different strategy than administering synthetic growth hormone, and it leans on the same machinery your body has always used to regulate GH

(6) Ipamorelin Peptide and Appetite The potential actions of Ipamorelin on ghrelin receptors may lead to an enhancement in hunger signals and, perhaps, an ensuing augmentation in body mass